Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities-Reference-Cited by-同舟云学术

Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities

Published:2023-02-22 Issue:5 Volume:66 Page:3135-3172
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Maity Pritam¹,Chatterjee Joydeep¹,Patil Kiran T.¹,Arora Sahil¹,Katiyar Madhurendra K.¹,Kumar Manvendra¹^ORCID,Samarbakhsh Amirreza²,Joshi Gaurav³^ORCID,Bhutani Priyadeep⁴,Chugh Manoj⁵,Gavande Navnath S.²⁶,Kumar Raj¹^ORCID

Affiliation:

1. Laboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, 151401 Bathinda, India

2. Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201, United States

3. Department of Pharmaceutical Science, Hemvati Nandan Bahuguna Garhwal (A Central) University, Srinagar 246174, Dist. Garhwal (Uttarakhand), India

4. Jubilant Biosys Limited, 560022 Bangalore, India

5. In Vitro Diagnostics, Transasia BioMedical Pvt. Ltd. 400072 Mumbai, India

6. Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, United States

Funder

Indian Council of Medical Research

Council of Scientific and Industrial Research, India

DMC Foundation

Bristol-Myers Squibb

U.S. Department of Defense

Wayne State University

National Institutes of Health